Computational study demonstrates favorable protease binding and drug-likeness for glucosyl nitrone cycloadducts, suggesting their potential as therapeutic inhibitors.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chellegui et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: